StockData
Cerenome, Inc. logo

Cerenome, Inc. (CNSY) shareholders

CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.63−0.08 (-11.82%)

Close on Nov 17, 2026Market cap $4.78MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
8.3%
1M of 8M shares
Institutional holders
21
8 new, 12 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Highbridge Capital Management, LLC13,157,8947.10%13G (passive)Mar 31, 2026
Heights Capital Management, Inc.
Joint filing with CVI Investments, Inc. (6.90%)
12,368,4236.90%13G (passive)Jan 14, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of CNSYValueChange% of portfolio
Vanguard Capital Management LLC304,7454.02%$1.33M+207,6610.00%
BlackRock, Inc.95,9831.26%$419.45K+24,9280.00%
Geode Capital Management, LLC76,1551.00%$332.94K−4,4970.00%
Vanguard Fiduciary Trust Co36,8680.49%$161.11K−9,6830.00%
Ashton Thomas Private Wealth, LLC34,3060.45%$149.92K+32,9890.00%
Citadel Advisors LLC25,5970.34%$111.86KNew0.00%
Northern Trust Corp15,5160.20%$67.81K+3,7840.00%
Virtu Financial LLC15,3430.20%$67.00KNew0.00%
Hrt Financial LP11,6120.15%$50.00KNew0.00%
Wells Fargo & Company/Mn6,1560.08%$26.90K+6,1540.00%
Vanguard Global Advisers, LLC2,2820.03%$9.97K−10.00%
Osaic Holdings, Inc.2,0000.03%$8.74K+1,9950.00%
Tower Research Capital LLC (TRC)1,9550.03%$8.54KNew0.00%
Allied Private Wealth LLC4960.01%$1.89KNew0.00%
UBS Group AG4700.01%$2.05K−3,0440.00%
SBI Securities Co., Ltd.2510.00%$1.10K+1450.00%
Morgan Stanley1850.00%$808New0.00%
Barclays PLC960.00%$420+960.00%
Citigroup Inc170.00%$74−3,7030.00%
Caitong International Asset Management Co., Ltd120.00%$52New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026211M8.3%8 / 85 / 120M0M
Q1 2026250M4.8%7 / 52 / 80M0M
Q4 2025270M6.1%11 / 91 / 60M0M
Q3 2025230M2.7%11 / 73 / 70M0M
Q2 2025190M0.2%8 / 34 / 60M0M
Q1 2025170M0.2%7 / 22 / 10M0M
Q4 2024110M0.4%2 / 20 / 20M0M
Q3 2024110M0.4%2 / 22 / 20M0M
Q2 2024120M0.4%4 / 30 / 20M0M
Q1 2024100M0.1%0 / 22 / 20M0M
Q4 2023120M0.1%3 / 31 / 30M0M
Q3 2023120M0.0%5 / 12 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

10 funds held CNSY in Q2 2026, 83% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of CNSYValue% of fundAs of
Vanguard Total Stock Market Index Fund203,5002.68%$889.30K0.00%Jun 30, 2026
Vanguard Extended Market Index Fund86,2451.14%$376.89K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund39,1440.52%$227.82K0.00%May 31, 2026
iShares Micro-Cap ETF23,4110.31%$102.31K0.01%Jun 30, 2026
Fidelity Series Total Market Index Fund10,3320.14%$60.13K0.00%May 31, 2026
Fidelity Total Market Index Fund9,9660.13%$58.00K0.00%May 31, 2026
Fidelity Nasdaq Composite Index Fund2,8490.04%$16.58K0.00%May 31, 2026
1290 VT Micro Cap Portfolio1,5180.02%$6.63K0.00%Jun 30, 2026
Total Stock Market Index Trust1350.00%$5900.00%Jun 30, 2026
Blackstone Alternative Multi-Strategy Fund200.00%$870.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Ronald Asbury AndrewsChief Business Officer, Director1,8430.02%Nov 12, 2026
Marc H. HedrickChief Executive Officer, Director105,7141.39%Oct 1, 2026
Andrew John Hugh MacIntyre SimsChief Financial Officer12,9260.17%Oct 1, 2026
Eric Joseph DanielsChief Development Officer0–Apr 22, 2026
Howard ClowesDirector2,9020.04%Oct 1, 2026
Kyle GuseDirector1,8430.02%Oct 1, 2026
Richard J. HawkinsDirector2,4500.03%Oct 1, 2026
Es-Johansson An vanDirector1,8430.02%Oct 1, 2026
Robert P. LenkDirector139,3271.84%Aug 25, 2025
Greg PetersenDirector48,9210.64%Feb 20, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Ronald Asbury Andrews
Director
Oct 1, 2026Option exercise+921––1,843
Howard Clowes
Director
Oct 1, 2026Option exercise+921––2,902
Es-Johansson An van
Director
Oct 1, 2026Option exercise+921––1,843
Richard J. Hawkins
Director
Oct 1, 2026Option exercise+921––2,450
Andrew John Hugh MacIntyre Sims
Chief Financial Officer
Oct 1, 2026Option exercise+287––12,926
Andrew John Hugh MacIntyre Sims
Chief Financial Officer
Oct 1, 2026Option exercise+1,165––12,639
Andrew John Hugh MacIntyre Sims
Chief Financial Officer
Oct 1, 2026Option exercise+1,533––11,474
Marc H. Hedrick
Chief Executive Officer, Director
Oct 1, 2026Option exercise+1,986––60,922
Marc H. Hedrick
Chief Executive Officer, Director
Oct 1, 2026Option exercise+8,066––58,936
Marc H. Hedrick
Chief Executive Officer, Director
Oct 1, 2026Option exercise+6,387––50,870
Kyle Guse
Director
Oct 1, 2026Option exercise+921––1,843
Marc H. Hedrick
Chief Executive Officer, Director
Jul 1, 2026Option exercise+1,986––44,483
Marc H. Hedrick
Chief Executive Officer, Director
Jul 1, 2026Option exercise+6,387––34,431
Marc H. Hedrick
Chief Executive Officer, Director
Jul 1, 2026Option exercise+8,066––42,497
Ronald Asbury Andrews
Director
Jul 1, 2026Option exercise+922––922
Howard Clowes
Director
Jul 1, 2026Option exercise+922––1,981
Andrew John Hugh MacIntyre Sims
Chief Financial Officer
Jul 1, 2026Option exercise+1,533––8,489
Andrew John Hugh MacIntyre Sims
Chief Financial Officer
Jul 1, 2026Option exercise+287––9,941
Andrew John Hugh MacIntyre Sims
Chief Financial Officer
Jul 1, 2026Option exercise+1,165––9,654
Kyle Guse
Director
Jul 1, 2026Option exercise+922––922
Richard J. Hawkins
Director
Jul 1, 2026Option exercise+922––1,529
Es-Johansson An van
Director
Jul 1, 2026Option exercise+922––922
Marc H. Hedrick
Chief Executive Officer, Director
Apr 1, 2026Option exercise+159,681––499,468
Marc H. Hedrick
Chief Executive Officer, Director
Apr 1, 2026Option exercise−201,632––701,100
Andrew John Hugh MacIntyre Sims
Chief Financial Officer
Apr 1, 2026Option exercise+29,129––173,913
Andrew John Hugh MacIntyre Sims
Chief Financial Officer
Apr 1, 2026Option exercise+38,323––144,784
Andrew John Hugh MacIntyre Sims
Chief Financial Officer
Jan 1, 2026Option exercise+38,323––106,461
Marc H. Hedrick
Chief Executive Officer, Director
Jan 1, 2026Option exercise+159,681––339,787
Andrew John Hugh MacIntyre Sims
Chief Financial Officer
Nov 4, 2025Buy+20,000$0.51$10.20K68,138
Marc H. Hedrick
Chief Executive Officer, Director
Oct 1, 2025Option exercise+159,681––180,106
Andrew John Hugh MacIntyre Sims
Chief Financial Officer
Oct 1, 2025Option exercise+38,323––48,138
Robert P. Lenk
Director
Aug 22, 2025Buy+110,000$0.49$53.90K139,327
Richard J. Hawkins
Director
Sep 13, 2024Buy+4,000$1.50$6.00K15,188
Richard J. Hawkins
Director
Sep 12, 2024Buy+6,285$1.35$8.48K11,188
Howard Clowes
Director
Sep 11, 2024Buy+5,000$1.34$6.70K26,497
Greg Petersen
Director
Sep 11, 2024Buy+12,500$1.35$16.88K48,921
Andrew John Hugh MacIntyre Sims
Chief Financial Officer
Sep 10, 2024Buy+4,098$1.27$5.20K9,815
Marc H. Hedrick
Chief Executive Officer, Director
Sep 10, 2024Buy+8,000$1.23$9.84K20,425
Robert P. Lenk
Director
May 8, 2024Buy+4,167$2.04$8.50K29,327
Andrew John Hugh MacIntyre Sims
Chief Financial Officer
May 8, 2024Buy+4,902$2.04$10.00K5,717
Howard Clowes
Director
May 8, 2024Buy+9,804$2.04$20.00K21,497
Greg Petersen
Director
May 8, 2024Buy+12,255$2.04$25.00K36,421
Marc H. Hedrick
Chief Executive Officer, Director
May 8, 2024Buy+12,255$2.04$25.00K12,425
Richard J. Hawkins
Director
May 8, 2024Buy+4,902$2.04$10.00K4,903
Marc H. Hedrick
Chief Executive Officer, Director
Nov 20, 2023Sale−2,068$1.96$4.05K170
Robert P. Lenk
Director
Nov 16, 2023Buy+1,000$1.95$1.95K25,160
Robert P. Lenk
Director
Nov 15, 2023Buy+1,000$1.77$1.77K24,160
Robert P. Lenk
Director
Nov 13, 2023Buy+4,000$1.43$5.72K23,160
Robert P. Lenk
Director
Nov 10, 2023Buy+2,000$1.45$2.90K19,160
Robert P. Lenk
Director
Nov 9, 2023Buy+4,199$1.59$6.68K17,160
Robert P. Lenk
Director
Nov 8, 2023Buy+5,000$1.65$8.25K12,961
Robert P. Lenk
Director
Nov 7, 2023Buy+6,000$1.64$9.84K7,961
Robert P. Lenk
Director
Nov 6, 2023Buy+1,395$1.50$2.09K1,961
Howard Clowes
Director
Sep 13, 2023Buy+6,993$1.43$10.00K11,693
Greg Petersen
Director
Sep 11, 2023Buy+20,000$1.70$34.00K24,166
Howard Clowes
Director
Jun 6, 2023Buy+1,000$3.98$3.98K4,700
Howard Clowes
Director
May 3, 2023Buy+2,500$3.64$9.10K3,700
Richard J. Hawkins
Director
Mar 3, 2023Buy+1$1000.00$1.00K1
Robert P. Lenk
Director
Dec 30, 2022Sale−1,500$0.31$4658,500
Marc H. Hedrick
Chief Executive Officer, Director
Jun 15, 2022Buy+5,000$0.65$3.25K33,580

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
11.61%
1M shares short
Days to cover
14.9
At 0M shares a day
Change since last report
+7.9%
From 1M shares
Short volume, 20 days
56.8%
Of volume reported to FINRA

Shares sold short, last 3 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Cerenome's stock actually held short. Settlement fails (shares not delivered on time) peaked at 29,577 shares on Oct 5, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Greg Petersen
Director
May 7, 202536,666$20.28KMay 15, 2025Market Buy

See a number that looks wrong?